Senior Director, Financial Planning & Analysis
SERVIER MONDE
Summary
Servier is seeking a strategic, enterprise-minded Senior Director, Financial Planning & Analysis (FP&A) to lead FP&A for its U.S. business during a period of significant growth, innovation, and portfolio expansion. Reporting to the U.S. Chief Financial Officer, this leader will oversee budgeting, forecasting, long-range planning, financial reporting, and business decision support while advising the Leadership Team and senior business leaders on capital allocation, portfolio prioritization, resource planning, and operational performance. The Senior Director will lead and develop the FP&A team, strengthen planning processes and systems, and help scale the Finance function as Servier continues to grow. This is a distinctive opportunity to shape financial strategy in a foundation-governed company with a continued focus on patient impact.
Job description
Role Summary
Servier is seeking a strategic, enterprise-minded Senior Director, Financial Planning & Analysis (FP&A) to lead FP&A for its U.S. business during a period of significant growth, innovation, and portfolio expansion. Reporting to the U.S. Chief Financial Officer, this leader will oversee budgeting, forecasting, long-range planning, financial reporting, and business decision support while advising the Leadership Team and senior business leaders on capital allocation, portfolio prioritization, resource planning, and operational performance. The Senior Director will lead and develop the FP&A team, strengthen planning processes and systems, and help scale the Finance function as Servier continues to grow. This is a distinctive opportunity to shape financial strategy in a foundation-governed company with a continued focus on patient impact.
Primary Responsibilities
- Lead enterprise-wide annual operating planning, rolling forecasting, and multi-year financial planning cycles.
- Provide executive-level financial insight, scenario modeling, and strategic recommendations to support capital allocation, portfolio prioritization, and resource decisions.
- Oversee financial performance management by identifying risks, opportunities, key business drivers, and required management actions.
- Partner with Accounting, Business, and Global Finance teams to ensure high-quality reporting, planning alignment, data integrity, and financial governance.
- Lead complex financial modeling for strategic investments, M&A, portfolio expansion, product revenue, and cost modeling.
- Advance FP&A systems, automation, dashboards, KPIs, and business intelligence tools to improve planning discipline and decision support.
- Develop executive-ready financial narratives and materials for Leadership Team and Management Team discussions.
- Build, mentor, and scale a high-performing FP&A team with a culture of accountability, partnership, and continuous improvement.
Required Qualifications
- Bachelor’s degree in Finance, Accounting, or a related field.
- MBA and or CPA preferred.
- 12+ years of progressive finance leadership experience, including significant experience in FP&A, enterprise financial planning, and business decision support.
- Experience in the biopharmaceutical, biotechnology, pharmaceutical, or life sciences industry.
- Demonstrated ability to translate complex financial data into clear, actionable strategic narratives for senior leaders.
- Strong analytical, strategic planning, financial modeling, and corporate decision-support capabilities.
- Proven ability to lead teams, influence cross-functional stakeholders, and operate effectively in a dynamic growth environment.
- Advanced proficiency with ERP systems such as SAP, business intelligence platforms such as Power BI or Tableau, and enterprise planning tools such as Adaptive Planning.
- Experience with preclinical and clinical development, commercial operations, technical operations, or small molecule products.
- Experience scaling finance processes, systems, and teams in a growing organization.
Key Leadership Attributes
- Enterprise mindset and ability to connect financial decisions to business strategy.
- Executive presence, sound judgment, and ability to influence senior stakeholders.
- Strong talent-development orientation and commitment to building high-performing teams.
- Operational discipline, change leadership, and continuous-improvement mindset.
Travel and Location
Travel: Approximately 15% travel required. Location: This is a hybrid role. The individual is expected to work in the office at least three days per week.
Requirements
- Bachelor’s degree in Finance, Accounting, or a related field.
- MBA and or CPA preferred.
- 12+ years of progressive finance leadership experience, including significant experience in FP&A, enterprise financial planning, and business decision support.
- Experience in the biopharmaceutical, biotechnology, pharmaceutical, or life sciences industry.
- Demonstrated ability to translate complex financial data into clear, actionable strategic narratives for senior leaders.
- Strong analytical, strategic planning, financial modeling, and corporate decision-support capabilities.
- Proven ability to lead teams, influence cross-functional stakeholders, and operate effectively in a dynamic growth environment.
- Advanced proficiency with ERP systems such as SAP, business intelligence platforms such as Power BI or Tableau, and enterprise planning tools such as Adaptive Planning.
- Experience with preclinical and clinical development, commercial operations, technical operations, or small molecule products.
- Experience scaling finance processes, systems, and teams in a growing organization.
Benefits
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Flexible Time Off
- Unlimited Sick Time
- 401(k)
- Life Insurance
- Disability Insurance
- Recognition Programs
- Short-Term Incentive Programs
- Long-Term Incentive Programs
Company overview
Servier, officially known as Laboratoires Servier, is a leading international pharmaceutical company founded in 1954 and headquartered in Suresnes, France. As the second largest French pharmaceutical group and the leading independent French pharmaceutical company, Servier operates in close to 140 countries worldwide, with 82% of its sales generated outside France. The company specializes in three main therapeutic areas: oncology, cardiometabolism & venous diseases, and neurology, with a particular focus on becoming a significant player in oncology, especially for rare cancers. Servier is governed by a unique non-profit foundation model that preserves its independence and allows for long-term strategic vision. The company invests approximately 20% of its brand-name medicine revenue into research and development annually, employing over 22,000 people globally, including 3,000 dedicated to R&D. With revenue of €5.9 billion in 2023/2024, Servier maintains 13 production sites and 6 research centers worldwide, producing 95.8% of active ingredients for its brand-name medicines in France. The company has established itself as a world leader in cardiology and hypertension treatments while expanding its oncology portfolio through strategic acquisitions and partnerships.